Clinical approach

Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos

History taking in patients with haematological disease - Physical examination - Splenomegaly - Lymphadenopathy - Unexplained anaemia - Patient with elevated haemoglobin - Elevated white blood cell (WBC) count - Reduced WBC count - Elevated platelet count - Reduced platelet count - Easy bruising - Recurrent thromboembolism - Pathological fracture - Raised ESR - Serum or urine paraprotein - Anaemia in pregnancy - Thrombocytopenia in pregnancy - Prolonged bleeding after surgery - Positive sickle test (HbS solubility test)

Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos ◽  
Hassan Al-Sader

History taking in patients with haematological disease - Physical examination - Splenomegaly - Lymphadenopathy - Unexplained anaemia - Patient with elevated haemoglobin - Elevated white blood cell (WBC) count - Reduced WBC count - Elevated platelet count - Reduced platelet count - Easy bruising - Recurrent thromboembolism - Pathological fracture - Raised ESR - Serum or urine paraprotein - Anaemia in pregnancy - Thrombocytopenia in pregnancy - Prolonged bleeding after surgery - Positive sickle test (HbS solubility test)


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 5070-5070
Author(s):  
Nanda K. Methuku ◽  
Nidhi Mishra ◽  
Gloria Fernandez ◽  
Praveena Coimbatore ◽  
Sammy Selahi

Abstract Abstract 5070 Title: A case of Hemophagocytic Lymphohistiocytosis with Acute Myelofibrosis Case report: A 60 year old previously healthy male was admitted for a four week history of non-productive cough, and intermittent fever which was getting worse since 1 week prior to presentation. He also had runny nose and nasal stuffiness 2 months prior to presentation. The patient also had significant weight loss of 30 lbs over the past month. Physical examination was remarkable for a temperature of 38°C. Patient was alert and oriented. No Lymphadenopathy or hepatosplenomegaly was found. Rest of the physical examination was otherwise unremarkable. Laboratory findings on admission: hemoglobin 10.1 g/dl, white blood cell count 1000 /ml (with 58.5% neutrophils, 36.9% lymphocytes 3.4% monocytes), platelet count 111,000 /ml, reticulocyte count 1.3 % and an erythrocyte sedimentation rate 4 mm, total bilirubin 0.8 mg/dL (with 0.4 mg/dL conjugated), alkaline phosphatase 62 U/L, AST 113 U/L, ALT 137 U/L, triglyceride 388 mg/dL, LDH 513 IU/L, ferritin was > 2000 ng/mL, PT 12.2 sec PTT 26.8 sec and fibrinogen 154 mg/dl No pathogens were isolated from throat, urine, feces, or blood. H1N1 testing; serological studies for hepatitis A, B, D, and E; Quantiferon test for tuberculosis; Serological studies for Human immunodeficiency virus (HIV), Cytomegalovirus (CMV), Epstein-Bar virus (EBV), parvovirus; antinuclear antibody, rheumatoid factor, lupus anticoagulant were all negative. Peripheral blood examination revealed normochromic-normocytic anemia. There was no evidence of micro-angiopathy or other marrow infiltration. A bone marrow biopsy was performed which showed a hypercellular marrow, with absence of myeloid precursors and decrease in erythroid cells. The predominant components were atypical megakaryocytes, plasma cells and eosinophils Reticulin stain showed marked increase in coarse reticulin. Occasional large histiocytes were visualized with engulfed lymphocytes, polymorphonuclear and red blood cells. Flow cytometry was negative for a myeloproliferative disorder. The platelet and WBC count nadirs were 73,000/mL and 800/mL (53% polymorphonuclear cells) at days 5–7 of admission. He continued to have cytopenias with intermittent febrile episodes despite being on broad spectrum antibiotics and antifungals. Based on pancytopenia, intermittent fever, elevated liver enzymes, very high ferritin level, high triglyceride level and evidence of hemophagocytosis on bone marrow exam a diagnosis of Hemophagocytic Lymphohistiocytosis was made. Patient received IV Ig for 2 days along with high dose steroids with prophylaxis with IV proton pump inhibitors, after which his fever resolved. LDH decreased from a peak of 900 to 300 and his leucopenia resolved with a WBC count of 3,000 /ml 5 days after 1st dose of IV Ig. Patient seemed to be responding very well to the treatment, but he had an episode of massive GI bleed on the fifteenth day of hospitalization with malena and he could not be resuscitated. No autopsy was performed. Discussion: We describe a case of possible secondary Hemophagocytic Lymphohistiocytosis (HLH) with Acute Myelofibrosis. A diagnosis of HLH was made based on the proposed diagnostic criteria, 2009 by Dr. Filipovich. Acute Myelofibrosis was evidenced by marked increase in reticulin stain with absence of splenomegaly or tear drop cells on peripheral blood smear. Viral infection could have been a trigger for HLH in this patient as he had runny nose 2 months before presentation. The patient responded very well to IVIg and high dose steroids as evidenced by an increase in WBC and platelet count, resolution of fever and decrease in LDH. HLH is a rare and potentially fatal condition with excessive activation of macrophages and T cells with an overwhelming systemic inflammatory reaction. Viruses are implicated as the most common triggers for secondary HLH. Our case adds to the literature on the rare disease and will help in understanding the disease better. Disclosures: No relevant conflicts of interest to declare.


PEDIATRICS ◽  
1994 ◽  
Vol 93 (2) ◽  
pp. 347-348
Author(s):  
Nicholas Paul Kokx

I would like the authors of the article "Guideline for Management of Fever Without Soource"1 to comment on the following questions, observations, and counter points: 1. How does the data in Table 1 on page 3 support option 2 (of Fig 2 on page 5) for outpatient management of "low-risk" infants 28 to 90 days old? Table 1 lists the risk for meningitis as 39/1000 for the toxic infant, and 5/1000 for low-risk infants (defined as previously healthy, nontoxic appearing febrile infants with a negative physical examination and a negative laboratory screen, ie, white blood cell (WBC) count >5000 and <15 000 with <1500 bands, a normal urinalysis, and <5 WBC/high-power field in stool if diarrhea is present).


2021 ◽  
Author(s):  
Shoujiang You ◽  
Guoli Xu ◽  
Yi Zhou ◽  
Chongke Zhong ◽  
Juping Cheng ◽  
...  

Abstract Background: High white blood cell (WBC) count was the risk factors for mortality and pneumonia after acute ischemic stroke (AIS). Low platelet count increased the risk of mortality. We investigated the combined effect of WBC count and platelet count on hospital admission and in-hospital mortality and pneumonia in acute AIS patients.Methods: A total of 3,265 AIS patients enrolled from December 2013 to May 2014 across 22 hospitals in Suzhou city were included in the present study. We divided patients into four groups according to their level of WBC count and platelet count: LWHP (low WBC and high platelet), LWLP (low WBC and low platelet), HWHP (high WBC and high platelet) and HWLP (high WBC and low platelet). Cox proportional logistic regression model were used to estimate the combined effect of WBC count and platelet count on all cause in-hospital mortality and pneumonia in AIS patients. Results: HWLP was associated with a 2.07-fold increase in the risk of in-hospital mortality in comparison to LWHP (adjusted odds ratio [OR] 2.07; 95% confidence interval [CI], 1.02-4.18; P-trend =0.020). The risk of pneumonia was significantly higher in patients with HWLP compared to those with LWHP (adjusted OR 2.29; 95% CI, 1.57-3.35; P-trend <0.001). The C-statistic for the combined WBC count and platelet count was higher than WBC count or platelet count alone for prediction of in-hospital mortality and pneumonia (all p < 0.01). Conclusions: High WBC count combined with low platelet count level at admission was independently associated with in-hospital mortality and pneumonia in AIS patients. Moreover, the combination of WBC count and platelet count level appeared to be a better predictor than WBC count or platelet count alone.


2021 ◽  
Vol 18 ◽  
Author(s):  
Shoujiang You ◽  
Xin Sun ◽  
Yi Zhou ◽  
Chongke Zhong ◽  
Juping Chen ◽  
...  

Background: We investigated the combined effect of white blood cell (WBC) and platelet count on in-hospital mortality and pneumonia in acute ischemic stroke (AIS) patients. Methods: A total of 3,265 AIS patients enrolled from December 2013 to May 2014 across 22 hospitals in Suzhou city were included in the present study. We divided patients into four groups according to their level of WBC and platelet count: LWHP (low WBC and high platelet), LWLP (low WBC and low platelet), HWHP (high WBC and high platelet), and HWLP (high WBC and low platelet). A logistic regression model was used to estimate the combined effect of WBC and platelet counts on all-cause in-hospital mortality and pneumonia in AIS patients. Results : HWLP was associated with a 2.07-fold increase in the risk of in-hospital mortality in comparison to LWHP (adjusted odds ratio [OR] 2.07; 95% confidence interval [CI], 1.02-4.18; P-trend =0.020). The risk of pneumonia was significantly higher in patients with HWLP than those with LWHP (adjusted OR 2.29; 95% CI, 1.57-3.35; P-trend <0.001). The C-statistic for the combined WBC and platelet count was higher than WBC count or platelet count alone for the prediction of in-hospital mortality and pneumonia (all P < 0.01). Conclusion: High WBC count combined with a low platelet count level at admission was independently associated with in-hospital mortality and pneumonia in AIS patients. Moreover, the combination of WBC count and platelet count level appeared to be a better predictor than WBC count or platelet count alone.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 5177-5177 ◽  
Author(s):  
Yellu Mehander ◽  
Stephen Medlin

Abstract Chronic myelogenous leukemia (CML) complicating pregnancy is rare and managing this specific subgroup of patients is challenging due to very limited data on this patient group. Management options differ depending on control of the CML at the time of the pregnancy. Patients who become pregnant during CML treatment with a TKI have been managed with watchful waiting, as well as Interferon-alpha, hydroxyurea, leukapheresis, and continuing tyrosine kinase inhibitors (TKI’s). Patients with concurrent diagnosis of CML and pregnancy present a more difficult management dilemma. In the absence of prospective trials, treatment has been tailored to individual patient needs and goals as well as past individual physician experience. The literature for treatment of CML in pregnancy is reviewed and a relevant case discussed. A 37 y/o woman with past medical history five miscarriages and asymptomatic mitral valve prolapse, presented for a routine visit in her first trimester. She complained of fatigue. CBC showed white blood cell (WBC) count at 189,000 with bone marrow consistent with CML and FISH positive for BCR-ABL. Patient was offered elective abortion but declined. She was started on interferon, 90mcg per week, which was then increased to 135mcg/week after about 3 weeks. Her elevated WBC count persisted and her symptoms as well. Second opinion led to initiation of leukapheresis mid-second trimester with an empiric goal of less than 100,000. She underwent once weekly leukapheresis without significant complications and within four weeks, her white blood cell count dropped to between 50,000 and 75,000, with hemoglobin between 8.5 and 9.7 and platelets of 450,000 to 550,000 until week 32. Her fatigue improved. She had been found to have a small placental abruption at her ultrasound in the second trimester prior to leukapheresis. This led to spotting and bed rest at 32 weeks. She delivered at 35 weeks with a healthy fetus. She had a pulmonary embolus complicating her period of bed rest. Pregnancy diagnosed concurrently with CML is uncommon and difficult to treat due to limited available options and lack of enough data about the potential harm to the fetus. Termination of pregnancy is considered safe for the mother when caught in the first trimester but was not desired in this case. Treatment during the second trimester with agents such as TKI’s is reported to be associated with fetal malformations. Interferon alpha therapy is FDA approved as category C in pregnancy, but can work slowly. Leukapheresis is thought to involve minimal risk to the fetus and minimize risk of complications of hyperleukocytosis. The effect of Leukapheresis is transient; therefore chance of rebound is high in rapidly proliferating leukemia. Successful use of leukapheresis has been reported in a few case reports. No specific guidelines have been developed to manage this specific group of patients. Use of TKI and other cytotoxic agents may be safer in third trimester but since enough data is not available to date, use of these agents cannot be recommended as routine therapy. Use of cytotoxic agents such as hydroxyurea may also be reasonable but also are not FDA approved for use. Leukapheresis may be a safe procedure to use in select situations when preservation of the fetus is desired, particularly during hyperleukocytosis. This procedure has very few complications and no major complications have been reported in the literature. Our patient had a PE after 2 weeks of strict bedrest in the hospital. This was not thought to be directly related to the underlying CML. The newborn was healthy at birth and the mother was treated with a TKI two weeks after delivery. Disclosures: No relevant conflicts of interest to declare.


2016 ◽  
Vol 62 (4) ◽  
pp. 377-384
Author(s):  
Robson Luis Oliveira de Amorim ◽  
Marcia Mitie Nagumo ◽  
Wellingson Silva Paiva ◽  
Almir Ferreira de Andrade ◽  
Manoel Jacobsen Teixeira

Summary In clinical practice, hospital admission of patients with altered level of consciousness, sleepy or in a non-responsive state is extremely common. This clinical condition requires an effective investigation and early treatment. Performing a focused and objective evaluation is critical, with quality history taking and physical examination capable to locate the lesion and define conducts. Imaging and laboratory exams have played an increasingly important role in supporting clinical research. In this review, the main types of changes in consciousness are discussed as well as the essential points that should be evaluated in the clinical management of these patients.


Angiology ◽  
2021 ◽  
pp. 000331972110211
Author(s):  
Buyun Jia ◽  
Chongfei Jiang ◽  
Yun Song ◽  
Chenfangyuan Duan ◽  
Lishun Liu ◽  
...  

Increased arterial stiffness is highly prevalent in patients with hypertension and is associated with cardiovascular (CV) risk. Increased white blood cell (WBC) counts may also be an independent risk factor for arterial stiffness and CV events. The aim of the study was to investigate the relationship between differential WBC counts and brachial-ankle pulse wave velocity (baPWV) in hypertensive adults. A total of 14 390 participants were included in the final analysis. A multivariate linear regression model was applied for the correlation analysis of WBC count and baPWV. Higher WBC counts were associated with a greater baPWV: adjusted β = 10 (95% CI, 8-13, P < .001). The same significant association was also found when WBC count was assessed as categories or quartiles. In addition, the effect of differential WBC subtypes, including neutrophil count and lymphocyte count on baPWV, showed the similar results. These findings showed that baPWV has positive associations with differential WBC counts in hypertensive adults.


Sign in / Sign up

Export Citation Format

Share Document